IDV vehicle
HT942523D0011
NOVEL NANOTHERAPEUTICS FOR COMBATTING PNEUMONIC PLAGUE
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | DEFENSE HEALTH AGENCY |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AJ11 — GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $0 |
| Current contract value | Not reported |
| Potential contract value / ceiling | $11.5M |
| Start date | Aug 15, 2023 |
| Current end date | Not available |
| Potential end date | Not available |
| Latest award activity | Mar 9, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Mar 9, 2026 | P00003 | $0 | NOVEL NANOTHERAPEUTICS FOR COMBATTING PNEUMONIC PLAGUE |
| Mar 3, 2026 | P00002 | $0 | NOVEL NANOTHERAPEUTICS FOR COMBATTING PNEUMONIC PLAGUE |
| May 12, 2025 | P00001 | $0 | NOVEL NANOTHERAPEUTICS |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.